| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $589K | -44.4% |
| Cost of Revenue | $334K | -44.2% |
| Gross Profit | $255K | -44.5% |
| R&D Expense | $1K | -90.6% |
| SG&A Expense | $245K | +32.3% |
| Operating Income | -$905K | -44.2% |
| Net Income | -$1.2M | -225.9% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $138K | +79.9% |
| Short-term Investments | $2K | -40.8% |
| Inventory | $98K | -13.9% |
| Current Assets | $308K | +6.0% |
| Total Assets | $400K | +34.2% |
| Current Liabilities | $3.1M | -1.5% |
| Total Liabilities | $3.3M | -3.6% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$498K | +10.6% |
| Capital Expenditures | $100K | — |
| Investing Cash Flow | -$99K | -167.6% |
| Financing Cash Flow | $658K | +81.7% |
| Free Cash Flow | -$598K | — |
| Stockholders' Equity |
| -$2.9M |
| +7.2% |